Welcome to our dedicated page for Valhi SEC filings (Ticker: VHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Valhi, Inc. filings document an NYSE-listed operating company with common stock trading under VHI and businesses in chemicals, component products, and real estate management and development. Form 8-K reports furnish quarterly and annual operating results, dividend announcements, material agreements and debt-related obligations involving affiliated chemicals operations, and officer or accounting-role changes.
Proxy materials cover annual meeting notices, director and stockholder voting matters, voting procedures, and governance information. The filing record also includes exhibits such as earnings releases, dividend releases, indenture-related agreements, and Inline XBRL cover-page data tied to Valhi's public-company reporting.
Hill Randy L reported acquisition or exercise transactions in this Form 4 filing.
VALHI INC /DE/ director Randy L. Hill received a grant of 3,150 shares of common stock on May 21, 2026. The award was priced at $12.66 per share for reporting purposes and was issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan.
After this stock award, Hill directly holds 3,150 shares of Valhi common stock. This is a compensation-related equity grant, not an open-market purchase or sale.
Tidlund Mary A. reported acquisition or exercise transactions in this Form 4 filing.
Valhi, Inc. director Mary A. Tidlund reported receiving an equity award of 3,150 shares of common stock at a reference value of $12.66 per share. These shares were issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan.
After this grant, she directly holds 10,391 common shares. This filing reflects a routine compensation-related stock award rather than an open-market purchase or sale.
Norris Gina A. reported acquisition or exercise transactions in this Form 4 filing.
Valhi, Inc. director Gina A. Norris received a grant of 3,150 shares of common stock, valued at $12.66 per share. The shares were issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan. After this award, she directly holds 5,450 shares.
Herrington Terri reported acquisition or exercise transactions in this Form 4 filing.
Valhi, Inc. director Terri Herrington reported an equity compensation grant of 3,150 shares of common stock at a reference value of $12.66 per share. The shares were issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan and are held directly. Following this award, Herrington directly holds a total of 10,058 Valhi common shares.
Valhi, Inc. director Loretta J. Feehan reported an acquisition of company stock through a compensation grant. She received 3,150 shares of common stock on May 21, 2026 at a reference price of $12.66 per share, issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan. Following this award, she directly holds a total of 10,641 common shares.
BARRY THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
Valhi, Inc. director Thomas E. Barry received a stock award of 3,150 common shares. The shares, with a reference value of $12.66 per share, were issued for no cash consideration under the Valhi, Inc. 2021 Non-Employee Director Stock Plan. This grant increases his direct ownership to 14,682 common shares.
VALHI INC /DE/ filed an initial ownership report for director Randy L. Hill. This Form 3 filing lists him as a director and indicates that there were no reportable transactions or holdings disclosed in this submission. It serves as his baseline insider reporting record with the company.
Valhi, Inc. announced that its board declared a regular quarterly cash dividend of $0.08 per share on common stock, payable on June 25, 2026, to stockholders of record as of June 4, 2026. This continues the company’s practice of returning cash to shareholders.
The company also reported results of its 2026 annual meeting. Stockholders representing 95.2% of the 28,302,293 shares eligible to vote participated, and all director nominees standing for election received at least 93.6% support. A nonbinding advisory resolution approving named executive officer compensation received 93.9% approval.
Following the meeting and a board vacancy caused by the death of director W. Hayden McIlroy, the board appointed Randy L. Hill, a longtime audit partner and current Opportune LLP partner, to the board and its audit committee, adding substantial financial and audit experience.
Valhi, Inc. reported net income attributable to stockholders of $2.0 million, or $0.07 per share, for the first quarter of 2026, down from $16.9 million, or $0.59 per share, a year earlier. Total net sales rose modestly to $560.1 million from $538.6 million, but total operating income declined to $32.9 million from $50.1 million.
The Chemicals Segment’s net sales increased to $509.8 million, helped by higher TiO2 volumes and favorable currency, yet operating income dropped sharply to $14.5 million from $41.2 million due to lower average TiO2 prices, lower production volumes, and adverse currency effects. Component Products delivered higher operating income of $7.1 million versus $5.9 million, and Real Estate Management and Development operating income jumped to $11.3 million from $3.0 million, supported by a $7.3 million commercial land sale and $5.4 million tax increment infrastructure reimbursement.
Results also reflect higher interest expense of $14.7 million and an income tax expense of $2.0 million related to an uncertain German tax position at the Chemicals Segment.
Valhi, Inc. reported sharply lower profitability for the quarter ended March 31, 2026. Net sales rose to $560.1 million from $538.6 million, but net income attributable to Valhi stockholders fell to $2.0 million, or $0.07 per share, versus $0.59 a year earlier.
The Chemicals segment remained the largest business with net sales of $509.8 million, yet its operating income dropped to $14.5 million from $41.2 million as TiO₂ selling prices were 6% lower and gross margin compressed from 22% to 16%. Component Products improved operating income to $7.1 million on slightly higher sales, while Real Estate Management and Development operating income jumped to $11.3 million, helped by a $7.3 million commercial land sale and $5.4 million of tax-increment infrastructure reimbursement.
Cash used in operating activities improved to $46.1 million from $155.9 million, but cash and cash equivalents declined to $193.7 million and total debt increased to $625.3 million. Management expects 2026 consolidated operating income to exceed 2025, driven by cost reductions in Chemicals and ongoing real estate revenue recognition, while noting continued uncertainty in TiO₂ demand, energy costs and geopolitical conditions.